Over the last half-century, psychedelics have radically transformed from public enemy number one to the plucky wunderkind promising to transform psychiatry, particularly mental health. Across the globe, ongoing studies are studying how psilocybin (the hallucinogen in “magic mushrooms”), MDMA (better known by its street name, ecstasy), and LSD could help conditions like depression or addiction as well as neurodegenerative conditions like Alzheimer’s.
